Schroeder Thomas M, Chintagumpala Murali, Okcu M Fatih, Chiu J Kam, Teh Bin S, Woo Shiao Y, Paulino Arnold C
Department of Radiation Oncology, University of New Mexico Cancer Center, The University of New Mexico, Albuquerque, NM, USA.
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):987-93. doi: 10.1016/j.ijrobp.2007.11.058. Epub 2008 Feb 6.
To determine the patterns of failure after intensity-modulated radiation therapy (IMRT) for localized intracranial ependymoma.
From 1994 to 2005, 22 children with pathologically proven, localized, intracranial ependymoma were treated with adjuvant IMRT. Of the patients, 12 (55%) had an infratentorial tumor and 14 (64%) had anaplastic histology. Five patients had a subtotal resection (STR), as evidenced by postoperative magnetic resonance imaging. The clinical target volume encompassed the tumor bed and any residual disease plus margin (median dose 54 Gy). Median follow-up for surviving patients was 39.8 months.
The 3-year overall survival rate was 87% +/- 9%. The 3-year local control rate was 68% +/- 12%. There were six local recurrences, all in the high-dose region of the treatment field. Median time to recurrence was 21.7 months. Of the 5 STR patients, 4 experienced recurrence and 3 died. Patients with a gross total resection had significantly better local control (p = 0.024) and overall survival (p = 0.008) than those with an STR. At last follow-up, no patient had developed visual loss, brain necrosis, myelitis, or a second malignancy.
Treatment with IMRT provides local control and survival rates comparable with those in historic publications using larger treatment volumes. All failures were within the high-dose region, suggesting that IMRT does not diminish local control. The degree of surgical resection was shown to be significant for local control and survival.
确定局部颅内室管膜瘤调强放射治疗(IMRT)后的失败模式。
1994年至2005年,22例经病理证实的局部颅内室管膜瘤患儿接受辅助IMRT治疗。其中12例(55%)为幕下肿瘤,14例(64%)为间变性组织学类型。5例患者术后磁共振成像显示为次全切除(STR)。临床靶区包括肿瘤床、任何残留病灶及边缘(中位剂量54 Gy)。存活患者的中位随访时间为39.8个月。
3年总生存率为87%±9%。3年局部控制率为68%±12%。有6例局部复发,均发生在治疗野的高剂量区域。复发的中位时间为21.7个月。5例STR患者中,4例复发,3例死亡。与STR患者相比,接受全切除的患者局部控制(p = 0.024)和总生存率(p = 0.008)明显更好。在最后一次随访时,没有患者出现视力丧失、脑坏死、脊髓炎或第二原发恶性肿瘤。
IMRT治疗提供的局部控制率和生存率与使用更大治疗体积的既往文献报道相当。所有失败均发生在高剂量区域,提示IMRT不会降低局部控制率。手术切除程度对局部控制和生存有显著影响。